Benigno Rodriguez Selected Research

Interferon Type I

1/2012	Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.
5/2009	Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benigno Rodriguez Research Topics

Disease

33	HIV Infections (HIV Infection) 01/2021 - 09/2003
24	Infections 01/2022 - 02/2003
10	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 12/2006
10	Inflammation (Inflammations) 01/2018 - 09/2010
7	Disease Progression 01/2017 - 09/2003
5	Coinfection 04/2019 - 02/2003
4	Substance-Related Disorders (Drug Abuse) 04/2019 - 01/2018
4	Hepatitis C 11/2018 - 09/2007
4	Viremia 06/2014 - 09/2003
3	Immune Reconstitution Inflammatory Syndrome 11/2014 - 07/2014
3	Lymphoma (Lymphomas) 07/2014 - 08/2013
3	Neoplasms (Cancer) 09/2013 - 01/2012
2	Fibrosis (Cirrhosis) 04/2019 - 01/2018
2	Chronic Hepatitis C 01/2018 - 03/2011
2	Tetanus 01/2018 - 09/2010
2	Hepatitis B 07/2014 - 05/2014
2	Virus Diseases (Viral Diseases) 03/2011 - 04/2007
1	Obesity 03/2020
1	Hypertension (High Blood Pressure) 03/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Alcoholism (Alcohol Abuse) 04/2019
1	Psychotic Disorders (Schizoaffective Disorder) 04/2019
1	Sepsis (Septicemia) 11/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2017
1	Retinitis 10/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2013
1	Periodontal Diseases (Periodontal Disease) 01/2013
1	Hemorrhage 01/2013
1	Chronic Renal Insufficiency 09/2012
1	Bacterial Vaginosis 09/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2012
1	Gingival Recession 11/2011

Drug/Important Bio-Agent (IBA)

14	RNA (Ribonucleic Acid)IBA 03/2019 - 02/2003
8	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2011
6	InterferonsIBA 04/2019 - 04/2012
5	Lipopolysaccharide ReceptorsIBA 01/2021 - 09/2012
5	CytokinesIBA 01/2018 - 06/2006
3	Antiviral Agents (Antivirals)IBA 04/2019 - 03/2005
3	AntigensIBA 01/2018 - 09/2010
3	VaccinesIBA 01/2018 - 01/2007
3	Maraviroc FDA Link 01/2017 - 06/2013
3	LipidsIBA 01/2017 - 09/2007
3	Proteins (Proteins, Gene)FDA Link 08/2013 - 02/2003
3	Thromboplastin (Tissue Factor)IBA 11/2012 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2014
2	Alanine Transaminase (SGPT)IBA 12/2014 - 02/2013
2	fibrin fragment D (D-dimer)IBA 10/2014 - 01/2013
2	Ribavirin (Virazole)FDA LinkGeneric 05/2014 - 09/2012
2	Messenger RNA (mRNA)IBA 01/2013 - 11/2008
2	Interferon-alpha (Interferon Alfa)IBA 01/2012 - 06/2006
2	Interferon Type IIBA 01/2012 - 05/2009
2	Pharmaceutical PreparationsIBA 09/2011 - 01/2010
2	LigandsIBA 01/2011 - 04/2007
2	ChemokinesIBA 11/2010 - 02/2007
2	B-Cell Activating FactorIBA 09/2010 - 09/2003
2	EnzymesIBA 01/2010 - 08/2006
2	Granzymes (Granzyme)IBA 11/2009 - 05/2009
2	Poly I-CIBA 05/2009 - 04/2007
1	Bacterial ToxinsIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 03/2020
1	sofosbuvir drug combination ledipasvirIBA 04/2019
1	Illicit Drugs (Recreational Drugs)IBA 04/2019
1	CholesterolIBA 11/2018
1	Oxygen (Dioxygen)IBA 11/2018
1	SuperantigensIBA 01/2017
1	lysophosphatidic acidIBA 11/2016
1	Carrier Proteins (Binding Protein)IBA 11/2016
1	Interleukin-7 (Interleukin 7)IBA 04/2016
1	Interleukin-15 (Interleukin 15)IBA 01/2016
1	oxidized low density lipoproteinIBA 06/2015
1	Chemokine ReceptorsIBA 11/2014
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2014
1	KynurenineIBA 10/2014
1	Tryptophan (L-Tryptophan)FDA Link 10/2014
1	Tenofovir (Viread)FDA Link 05/2014
1	DNA (Deoxyribonucleic Acid)IBA 05/2014
1	Biological ProductsIBA 08/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2013
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 08/2013
1	PyrophosphatasesIBA 08/2013
1	ProteomeIBA 08/2013
1	Aspartic Acid (Aspartate)FDA Link 02/2013
1	Hemoglobins (Hemoglobin)IBA 02/2013
1	CreatinineIBA 02/2013
1	Tuberculin (PPD)IBA 01/2013
1	Anti-HIV Agents (AIDS Drugs)IBA 01/2013
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2013
1	FlagellinIBA 10/2012
1	beta-DefensinsIBA 09/2012
1	P-SelectinIBA 04/2012
1	ErbB Receptors (EGF Receptor)IBA 01/2012
1	Cetuximab (Erbitux)FDA Link 01/2012
1	antineoplaston A10 (A 10)IBA 11/2011

Therapy/Procedure

22	Therapeutics 01/2020 - 09/2003
16	Art Therapy 01/2018 - 12/2006
5	Highly Active Antiretroviral Therapy (HAART) 09/2013 - 02/2003
1	Retention in Care 01/2018
1	Drug Therapy (Chemotherapy) 01/2012